Adagio Medical has initiated a strategic review of its business and will lay off more than half its full-time workers as the maker of cryoablation ablation devices faces delisting on the Nasdaq exchange.
Adagio Medical has initiated a strategic review of its business and will lay off more than half its full-time workers as the maker of cryoablation ablation devices faces delisting on the Nasdaq exchange.
